Global Chronic, Acute, and Neuropathic Pain Market: Opioids to Remain Most Valued Drug for Chronic Pain
The research report, titled "Frontier Pharma: Chronic, Acute And Neuropathic Pain - GPCR And Nerve Growth Factor-Based Therapies Offer Strong Potential In Difficult-To-Treat Subtypes," analyzes the historical as well as the existing performance of this market, emphasizing specifically on various types of therapies applied to treat chronic, acute, and neuropathic pain.
View full press release